Cytokinetics, Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 19.08 M | $1.05 B | 8.40% | 15.97% |
| BLACKROCK, INC. | 11/12/2025 | 15.53 M | $853.30 M | -0.97% | 13.00% |
| FMR LLC | 11/13/2025 | 13.09 M | $719.52 M | 16.19% | 10.96% |
| VANGUARD GROUP INC | 11/07/2025 | 11.86 M | $651.65 M | -1.06% | 9.93% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 7.41 M | $407.17 M | -5.35% | 6.20% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2025 | 6.00 M | $6.86 M | 100.00% | 5.02% |
| STATE STREET CORP | 11/14/2025 | 5.62 M | $308.73 M | -11.85% | 4.70% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 4.30 M | $236.33 M | 17.81% | 3.60% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 3.06 M | $168.28 M | 15.73% | 2.56% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 3.04 M | $167.11 M | 1.53% | 2.55% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 2.78 M | $152.95 M | -0.55% | 2.33% |
| RTW INVESTMENTS, LP | 11/14/2025 | 2.72 M | $149.55 M | 0.00% | 2.28% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 2.37 M | $130.08 M | 26.84% | 1.98% |
| UBS GROUP AG | 11/13/2025 | 1.80 M | $99.11 M | -41.27% | 1.51% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.65 M | $90.56 M | 676.12% | 1.38% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.63 M | $89.84 M | 28.32% | 1.37% |
| JPMORGAN CHASE & CO | 11/26/2025 | 1.54 M | $84.80 M | 17.11% | 1.29% |
| MORGAN STANLEY | 11/14/2025 | 1.52 M | $83.60 M | 36.05% | 1.27% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.41 M | $77.32 M | 2.00% | 1.18% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 1.40 M | $76.94 M | 40.00% | 1.17% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.39 M | $76.18 M | 6.73% | 1.16% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.37 M | $75.51 M | 1.24% | 1.15% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 1.20 M | $65.78 M | -8.80% | 1.00% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 11/12/2025 | 1.19 M | $65.54 M | 10.15% | 1.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.19 M | $65.47 M | 299.63% | 1.00% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 1.18 M | $64.79 M | 0.91% | 0.99% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 1.17 M | $64.55 M | -0.87% | 0.98% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.15 M | $62.87 M | -25.92% | 0.96% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.02 M | $55.94 M | 41.20% | 0.85% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 950.00 K | $52.21 M | -29.10% | 0.80% |
| ABRDN PLC | 11/07/2025 | 927.83 K | $50.99 M | 0.53% | 0.78% |
| BROWN ADVISORY INC | 11/14/2025 | 912.19 K | $50.13 M | -8.35% | 0.76% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 890.45 K | $48.94 M | 60.52% | 0.75% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 869.23 K | $47.77 M | -0.58% | 0.73% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 785.00 K | $43.14 M | 16.08% | 0.66% |
| MELQART ASSET MANAGEMENT (UK) LTD | 11/14/2025 | 783.77 K | $43.08 M | -40.92% | 0.66% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 761.59 K | $41.86 M | 3.80% | 0.64% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 750.00 K | $41.22 M | 50.00% | 0.63% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 725.00 K | $39.85 M | -75.63% | 0.61% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 671.78 K | $36.92 M | 23.42% | 0.56% |
| JANE STREET GROUP, LLC | 11/14/2025 | 601.30 K | $33.05 M | 16.42% | 0.50% |
| SARISSA CAPITAL MANAGEMENT LP | 11/14/2025 | 588.36 K | $32.34 M | 0.00% | 0.49% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 564.55 K | $31.03 M | 63.65% | 0.47% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 518.92 K | $28.52 M | -10.86% | 0.43% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 513.29 K | $28.21 M | 47.61% | 0.43% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 496.67 K | $27.30 M | -0.19% | 0.42% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 471.48 K | $25.91 M | 100.00% | 0.39% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 11/14/2025 | 458.30 K | $25.19 M | 100.00% | 0.38% |
| CATALIO CAPITAL MANAGEMENT, LP | 11/14/2025 | 451.58 K | $24.82 M | -24.92% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 436.20 K | $23.97 M | 105.85% | 0.37% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cytokinetics, Incorporated institutional Ownership - FAQ's
During the previous two years, 494 institutional investors and hedge funds held shares of Cytokinetics, Incorporated. The most heavily invested institutionals were:
T. Rowe Price Investment Management, Inc.: 19.08 M
BlackRock, Inc.: 15.53 M
FMR LLC: 13.09 M
VANGUARD GROUP INC: 11.86 M
WELLINGTON MANAGEMENT GROUP LLP: 7.41 M
TUDOR INVESTMENT CORP ET AL: 6 M
122.96% of Cytokinetics, Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 179.07 M shares in the last 24 months. This purchase volume represents approximately $11.92 B in transactions.